A detailed history of Massmutual Trust CO Fsb transactions in Incyte Corp stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 937 shares of INCY stock, worth $66,095. This represents 0.0% of its overall portfolio holdings.

Number of Shares
937
Previous 1,009 7.14%
Holding current value
$66,095
Previous $61,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$57.33 - $68.61 $4,127 - $4,939
-72 Reduced 7.14%
937 $61,000
Q2 2024

Jul 02, 2024

BUY
$51.18 - $63.75 $13,204 - $16,447
258 Added 34.35%
1,009 $61,000
Q1 2024

Apr 09, 2024

BUY
$56.55 - $66.59 $1,979 - $2,330
35 Added 4.89%
751 $42,000
Q4 2023

Jan 03, 2024

SELL
$52.16 - $64.19 $4,642 - $5,712
-89 Reduced 11.06%
716 $44,000
Q3 2023

Oct 03, 2023

BUY
$57.77 - $65.93 $2,772 - $3,164
48 Added 6.34%
805 $46,000
Q2 2023

Aug 01, 2023

BUY
$60.95 - $75.51 $26,330 - $32,620
432 Added 132.92%
757 $47,000
Q1 2023

Apr 11, 2023

BUY
$70.23 - $86.01 $3,511 - $4,300
50 Added 18.18%
325 $23,000
Q4 2022

Jan 06, 2023

SELL
$67.18 - $84.11 $873 - $1,093
-13 Reduced 4.51%
275 $22,000
Q3 2022

Oct 07, 2022

BUY
$66.18 - $82.86 $4,831 - $6,048
73 Added 33.95%
288 $19,000
Q2 2022

Jul 07, 2022

SELL
$66.18 - $83.18 $992 - $1,247
-15 Reduced 6.52%
215 $16,000
Q1 2022

Apr 08, 2022

BUY
$66.02 - $79.71 $1,188 - $1,434
18 Added 8.49%
230 $18,000
Q4 2021

Feb 09, 2022

BUY
$63.34 - $74.11 $1,140 - $1,333
18 Added 9.28%
212 $16,000
Q3 2021

Nov 12, 2021

SELL
$68.67 - $84.02 $343 - $420
-5 Reduced 2.51%
194 $13,000
Q2 2021

Aug 16, 2021

BUY
$79.87 - $87.53 $12,379 - $13,567
155 Added 352.27%
199 $17,000
Q1 2021

May 17, 2021

BUY
$76.02 - $100.5 $3,344 - $4,422
44 New
44 $4,000
Q2 2018

Aug 20, 2018

SELL
$60.85 - $83.98 $851 - $1,175
-14 Closed
0 $0
Q1 2018

May 21, 2018

BUY
$83.06 - $100.98 $1,162 - $1,413
14 New
14 $1.17 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.7B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.